At ABVD, we are shaping the future of biologics and vaccine manufacturing. Our 12-week immersive training program is designed for students and professionals in Life Science, Biology related Technology or Engineering field who want hands-on experience in cutting-edge biopharmaceutical technologies.
From mRNA vaccine development to cell and gene therapies, this program takes you through the entire biomanufacturing process—from computational biology-driven molecule identification to cGMP-compliant drug substance and product manufacturing. You’ll also gain expertise in quality control (QC), quality assurance (QA), process validation, and regulatory pathways to drug approval.
By the end of this course, you won’t just understand the science—you’ll be ready to apply it in real-world biomanufacturing settings.
At ABVD, we believe that talent should not be limited by financial barriers. Our mission is to empower the brightest minds with the knowledge and skills to drive biopharmaceutical future.
Once accepted, you’ll receive a detailed onboarding email with everything you need to prepare for your first day.
Registration Closed
Thank you for your incredible interest in the ABVD 5-day malaria mRNA training! We received far more applications than expected, so registration is now closed.
If you’ve already applied, we’ll update you soon on your selection status.
Don’t miss out on what’s coming next—new trainings, expanding programs, job opportunities, and hands-on lab projects are on the way.
Register and opt in for our newsletter to stay connected.
Interested in advancing your expertise in malaria mRNA vaccine development ?
Join our 5-Day Intensive Training on Malaria mRNA Vaccine Development.
Register now through the link below or visit our homepage and sign up under Account section.
Selected candidates will be contacted by ABVD with next steps.
Registration closes November 26, 2025- don’t miss your chance to be part of this groundbreaking initiative!
Free all Expenses Paid for (transportation, meals, accommodation, and training)